GENOMICS LIVE AGENDA

 

DOWNLOAD LATEST AGENDA

 

Basel, 4 - 5 December 2019

Schedule

Create your personal agenda –check the favourite icon

Dec 409:00
Conference pass

Chair's Opening Remarks

Keynotes
Corinne Solier, Global Head Biomics and Pathology, Roche Pharma
Dec 409:10
Conference pass

Genomics for better health

Keynotes
Isabel De La Mata, Principal Advisor For Health And Crisis Management, European Commission
Dec 409:40
Conference pass

Big Data & Machine Learning for Neoantigens, Vaccines and TCRs

Keynotes
John Castle, Head Of Translational Medicine And Bioinformatics, Agenus
Dec 410:10
Conference pass

Accelerating Drug Development Using CtDNA

Keynotes
Dec 411:40
Conference pass

Roundtables

Keynotes
"Tissunomics" - how to integrate clinical and molecular data in tissue diagnostics
Santiago Ramon Y Cajal, Chairman Of Pathology Department, Vall Dhebron Barcelona Hospital Campus
Commercial Diagnostic strategy in a changing diagnostic landscape
Jens Klabunde, Diagnostics Strategy Leader, Personalized Healthcare, Roche
Epigenetics: drivers or passengers in transcription regulation and disease etiology
How to integrate liquid biopsies into routine care
Integrating Genomics into routine clinical trials
Making Digital Pathology Data Mineable
Pierre Moulin, Global Head Of Pathways And Molecular Pathology, Novartis International AG
Overcoming public health system challenges to relfex BRCA somatic tissue testing
Pre-analytics for CTC liquid biopsies
Pamela Pinzani, Associate Professor, University of Florence
Precision Medicine using rapid WGS
Ray Veeraraghavan, Senior Director, Informatics and Im, Rady Children's Institute for Genomic Medicine
The present and the future of patient stratification for Immunotherapy
Philip Jermann, Head Of Molecular Assay Development Unit, University Hospital Basel
The right tools for the job: which technology for my question?
Dec 413:30
Conference pass
Dec 413:30
Conference pass

Chair's Remarks

Circulating Tumour DNA & Liquid Biopsy
Dec 413:30
Conference pass
Dec 413:30
Conference pass

Chair's Remarks

Immuno-oncology & Companion Diagnostics
Jens Klabunde, Diagnostics Strategy Leader, Personalized Healthcare, Roche
Dec 413:35
Conference pass

Predicting Breast Cancer Survival using Digital Pathology

Digital Pathology
Dec 413:35
Conference pass
Dec 413:35
Conference pass

Molecular Diagnostic Informational Management Systems

Biobanking & Tissue Management
Dec 413:35
Conference pass

Challenges, Opportunities and Newest Applications for Molecular Tumor Diagnostics

Immuno-oncology & Companion Diagnostics
Dec 413:55
Conference pass

AI-based automated image analysis for high-throughput neuroanatomy and histopathology

Digital Pathology
Dec 413:55
Conference pass

The other nucleic acid: Enabling precision medicine through the study of RNA in liquid biopsies

Circulating Tumour DNA & Liquid Biopsy
Dec 413:55
Conference pass

The TLA Technology & complete gene sequencing for precision cancer medicine

Immuno-oncology & Companion Diagnostics
Dec 414:05
Conference pass

Implementation of a genomics service into a National Healthcare system- a regional approach

Biobanking & Tissue Management
Dec 414:15
Conference pass

Diving deep into tissue: Unleashing it's potential for biomarker R&D using digital image analysis

Digital Pathology
Dec 414:15
Conference pass
Dec 414:15
Conference pass

Genomic Profiling in Immunotherapy response

Immuno-oncology & Companion Diagnostics
Dec 415:05
Conference pass
Dec 415:05
Conference pass

Chair's Remarks

Circulating Tumour DNA & Liquid Biopsy
Dec 415:05
Conference pass
Dec 415:05
Conference pass

Chair's Remarks

Immuno-oncology & Companion Diagnostics
Dec 415:10
Conference pass

Quantification issues in tissue samples: using histology to support clinically relevant biomarkers

Digital Pathology
Dec 415:10
Conference pass

Novel digital PCR and mutation enrichment technologies for detecting minimal residual disease and monitoring in liquid biopsies

Circulating Tumour DNA & Liquid Biopsy
Dec 415:10
Conference pass

Genomics in LIFE - Experiences from the Leipzig Research Center for Civilisation Diseases (LIFE)

Biobanking & Tissue Management
Dec 415:10
Conference pass

Imaging – Tool for Biomarker Assessment Without Molecular Testing

Immuno-oncology & Companion Diagnostics
Bin Feng, Senior Director, Head Of Advanced Analytics And Experimental Medicine Unit, GSK
Dec 415:30
Conference pass

Assessing and Improving ctDNA Assay Performance Through Standards and Collaborations

Circulating Tumour DNA & Liquid Biopsy
Dec 415:30
Conference pass

How clinical biobanks can support precision medicine: a Lübeck and ESBB perspective

Biobanking & Tissue Management
Dec 415:30
Conference pass

Organizing your Repertoire Sequencing data using the IGX Platform

Immuno-oncology & Companion Diagnostics
Josine Oude Lohuis, IGX Application Specialist, ENPICOM
Dec 415:40
Conference pass
Dec 415:50
Conference pass

Detection, Characterization and ex vivo Expansion of Viable Circulating Tumour Cells (CTCs)

Circulating Tumour DNA & Liquid Biopsy
Dec 415:50
Conference pass

Infrastructures for precision medicine research: Biobanking at a global scale

Biobanking & Tissue Management
Dec 415:50
Conference pass

Comparison of tumour profiling assays used in breast cancer clinic

Immuno-oncology & Companion Diagnostics
Dec 416:50
Conference pass

Chair's Remarks

Digital Pathology
Pierre Moulin, Global Head Of Pathways And Molecular Pathology, Novartis International AG
Dec 416:50
Conference pass

Chair's Remarks

Circulating Tumour DNA & Liquid Biopsy
Janet Jin, Director, Clinical Biomarkers And Cdx, AbbVie
Dec 416:50
Conference pass
Dec 416:50
Conference pass

Chair's Remarks

Immuno-oncology & Companion Diagnostics
Rhoda Molife, Senior Clinical Director, MSD
Dec 416:55
Conference pass

Learned representations from normal tissues - Accelerating exploration for computational pathology

Digital Pathology
Dec 416:55
Conference pass

Tracking circulating tumor DNA for cancer patient follow up

Circulating Tumour DNA & Liquid Biopsy
Dec 416:55
Conference pass

Scottish Population Research Biobanks – balancing use, ethics and access to genetic results

Biobanking & Tissue Management
Dec 416:55
Conference pass

Moving towards an Integrative diagnostic immuno-oncology platform

Immuno-oncology & Companion Diagnostics
Dec 417:15
Conference pass

Label-free digital pathology provides automated tissue classification without inter observer variability

Digital Pathology
Klaus Gerwert, Professor, Ruhr University Bochum
Dec 417:15
Conference pass

Value proposition for advanced molecular diagnostics in non-small cell lung cancer

Circulating Tumour DNA & Liquid Biopsy
Dec 417:15
Conference pass

Working towards a fully automated liquid biobank

Biobanking & Tissue Management
Dec 417:15
Conference pass

Avoiding the Biomarker graveyard-  Jumping the valley of death between academia and industry

Immuno-oncology & Companion Diagnostics

Create your personal agenda –check the favourite icon

Dec 509:00
Conference pass
Dec 509:10
Conference pass

Developing Biomarkers for an NTRK Inhibitor in a tissue agnostic indication

Keynotes
Nicoletta Brega, Global Medical Expert And Head Of Ta Oncology, Bayer
Dec 510:40
Conference pass

Challenges and Opportunities for Biomarkers in Early Clinical Development

Keynotes
Bruno Gomes, Global Head Of Biomarkers Oncology, Roche
Dec 511:40
Conference pass

Roundtables

Keynotes
Best practice for analytical techniques to improve precision medicine
Markus Paulmichl, Chair Of Department Of Personalised Medicine, Humanomed
Computational drug repurposing in the time of ML/AI - where are we now?
Charles Roberts, Co Founder And Chief Partnership Officer, Freenome
Current technologies and future challenges in single cell research
Exome Sequencing for Precision Medicine
From targeting tumor mutations to finding cancer predisposition genes: the other side of the coin
How can academics and industry work together to turn basic science into better patient outcomes
How can we obtain the maximum information from liquid biopsies and translate it to the clinic?
Lorena Dieguez, Group Head, Nano4Health Unit, International Iberian nanotechnology laboratory
Overcoming the challenges of implementing genomics in healthcare
Rolf Apweiler, Embl-Ebi Director, EMBL- EBI
Single Cell Analysis---Clinical purposes and methods: from dissociation to comprehensive analysis of single cells
Tumor evolution and clinical trajectories of prostate cancer. Targeting the root of the disease
Dec 513:30
Conference pass
Dec 513:30
Conference pass

Chair's Remarks

Flow Cytometry & Single Cell Analysis
Dec 513:30
Conference pass
Dec 513:35
Conference pass

Integrated omics for mapping the human proteome in health and disease

Molecular Diagnostics
Cecilia Lindskog, Director Human Tissue Atlas, Uppsala University
Dec 513:35
Conference pass
Dec 513:35
Conference pass

Precision Medicine in Melanoma

Precision Medicine
Dec 513:55
Conference pass

Evolutionary trajectories of prostate cancer to detect early markers of the disease

Molecular Diagnostics
Joachim Weischenfeldt, Group Leader, Biotech Research And Innovation Centre
Dec 513:55
Conference pass

Unprecedented Innovation in NGS: what is needed to disrupt the current paradigm for molecular testing in oncology

Cancer Diagnostics
Dec 513:55
Conference pass

Precision Medicine in Pfizer’s Early Clinical Portfolio

Precision Medicine
Dec 513:55
Conference pass

Resolving Biology: From Single Cell to Spatial Transcriptomics

Flow Cytometry & Single Cell Analysis
Dec 514:15
Conference pass

Development of an integrated platform for biomarker and drug target discovery using proteomics

Molecular Diagnostics
Tony Whetton, Director, Stoller Biomarker Discovery Centre
Dec 514:15
Conference pass

Coordinating molecular testing and patient stratification within a national health care system

Cancer Diagnostics
Dec 514:15
Conference pass

Benchmarking single-cell sequencing technologies for drug discovery applications

Flow Cytometry & Single Cell Analysis
Dec 514:15
Conference pass

Presentation by CytoReason

Precision Medicine
Shai Shen-Orr, Chief Scientist, CytoReason
Dec 515:15
Conference pass
Dec 515:15
Conference pass
Dec 515:15
Conference pass

Chair's Remarks

Flow Cytometry & Single Cell Analysis
Dec 515:15
Conference pass

Chair's Remarks

Precision Medicine
Eike Staub, Director, Head Of Oncology Bioinformatics, Merck Group
Dec 515:20
Conference pass

Finding signals in noise: counting peptides with a DNA sequencer

Molecular Diagnostics
Dec 515:20
Conference pass
Dec 515:20
Conference pass

Disease-associated cell populations for Drug Discovery

Flow Cytometry & Single Cell Analysis
Dec 515:20
Conference pass
Dec 515:40
Conference pass

Enabling quantification of tissue specific lncRNAs in blood: An innovative tool for Dx-Tx target discovery

Molecular Diagnostics
Dec 515:40
Conference pass

Clonal architecture of ALL at diagnosis and during chemotherapy treatment revealed by single-cell DNA sequencing

Cancer Diagnostics
Dec 515:40
Conference pass

Development of a Digital X-Omics Platform for ClinicalN Research on Big Biomarker Data

Precision Medicine
Eike Staub, Director, Head Of Oncology Bioinformatics, Merck Group
Dec 515:40
Conference pass

Single Cell RNA-Seq Data Analysis Made Simple

Flow Cytometry & Single Cell Analysis
Dec 516:00
Conference pass

Personalized medicine; more than planning, doing

Molecular Diagnostics
Dec 516:00
Conference pass

Clinical Application of Molecular Tumor Profiling for Best Oncology Care

Cancer Diagnostics
Dec 516:00
Conference pass

Non-Invasive Prenatal Screening (NIPS) based on Limited Template

Flow Cytometry & Single Cell Analysis
Michael Sinosich, Scientific Director, Prenatal Testing, Sonic Healthcare Ltd
Dec 516:00
Conference pass

Transitioning complex cancer genomics into routine oncology practice

Precision Medicine
Dec 517:00
Conference pass

Chair's Remarks

Molecular Diagnostics
Ed Schuuring, Professor In Molecular Oncological Pathology, University of Groningen
Dec 517:00
Conference pass

Chair's Remarks

Cancer Diagnostics
Wolfgang Hackl, Founder, OncoGenomX
Dec 517:00
Conference pass

Chair's Remarks

Precision Medicine
Martin Armstrong, Senior Director Molecular Genetics, Experimental Medicine And Diagnostics, UCB
Dec 517:00
Conference pass

Chair's Remarks

Flow Cytometry & Single Cell Analysis
Dec 517:05
Conference pass

MiRNAs as a diagnostic tool to predict Blood Brain Barrier impairment

Molecular Diagnostics
Dec 517:05
Conference pass

Cancer genomics portfolio for diagnostics, clinical trials and translational research in the Stockholm healthcare region

Cancer Diagnostics
Dec 517:05
Conference pass

Mining the cancer cell surfaceome for therapeutic applications

Flow Cytometry & Single Cell Analysis
Dec 517:05
Conference pass

Two decades of pharmacogenetics research at GSK: patient impacts and future directions

Precision Medicine
Charles Cox, Head Of Pharmacogenetics, Genetics, Target Sciences, G.S.K. R and D
Dec 517:25
Conference pass

Molecular Pathology in the Netherlands

Molecular Diagnostics
Ed Schuuring, Professor In Molecular Oncological Pathology, University of Groningen
Dec 517:25
Conference pass

WHO International Standards for Cancer Genomic Diagnostics

Cancer Diagnostics
Dec 517:25
Conference pass
Dec 517:25
Conference pass

Using SERS and microdroplets for analysis of single tumor cells

Flow Cytometry & Single Cell Analysis
Lorena Dieguez, Group Head, Nano4Health Unit, International Iberian nanotechnology laboratory
last published: 29/Nov/19 13:55 GMT

 

Contact us

To sponsor or exhibit contact:
Harry Ludbrook
+44 (0)207 092 1049

Harry.Ludbrook@terrapinn.com


To speak:
Diana Georgi
+44 (0)20 7092 1075

Diana.georgi@terrapinn.com